Skip to Content

864 (Topiramate Extended-Release 50 mg)

Pill with imprint 864 is White, Capsule-shape and has been identified as Topiramate Extended-Release 50 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Topiramate is used in the treatment of epilepsy; seizure prevention; lennox-gastaut syndrome; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 864

Topiramate extended-release 50 mg 864

Topiramate Extended-Release

Imprint
864
Strength
50 mg
Color
White
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0864
Inactive Ingredients
ethylcelluloses, isopropyl alcohol, hypromelloses, hydrogenated castor oil, microcrystalline cellulose, povidone, polyethylene glycol, magnesium silicate, triethyl citrate, gelatin, sodium lauryl sulfate, titanium dioxide, butyl alcohol, alcohol, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, ammonia, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "864"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.